- Agios Pharmaceuticals, Inc. stock price today and history
Agios Pharmaceuticals, Inc. (AGIO) stock prices updated...
Please, Signup (Login) to subscribe or trade (demo)
Agios Pharmaceuticals, Inc. stock price
Agios Pharmaceuticals, Inc. latest news:
BRIEF-Agios says FDA Accepts NDA And Grants Priority Review For Ivosidenib
Agios Pharmaceuticals Inc(AGIO): * FDA ACCEPTS NEW DRUG APPLICATION AND GRANTS PRIORITY REVIEW FOR IVOSIDENIB IN RELAPSED OR REFRACTORY AML WITH AN IDH1 MUTATION. * FDA ACCEPTS NEW DRUG APPLICATION AND GRANTS PRIORITY REVIEW FOR IVOSIDENIB IN RELAPSED OR REFRACTORY AML WITH AN IDH1 MUTATION.
BRIEF-Agios prices offering of 7.09 mln shares at $67 per share
Agios Pharmaceuticals Inc(AGIO): * AGIOS ANNOUNCES PRICING OF $475 MILLION PUBLIC OFFERING OF COMMON STOCK. * AGIOS PHARMACEUTICALS(AGIO) - IT HAS PRICED AN UNDERWRITTEN PUBLIC OFFERING OF 7.09 MILLION SHARES OF COMMON STOCK AT A PRICE TO PUBLIC OF $67.00 PER SHARE Source text for Eikon: Further company coverage:
BRIEF-Agios Announces Proposed Offering Of Common Stock
Agios Pharmaceuticals Inc(AGIO): * AGIOS ANNOUNCES PROPOSED OFFERING OF COMMON STOCK. * SAYS IT IS OFFERING TO SELL UP TO $400 MILLION OF ITS COMMON STOCK IN A PUBLIC OFFERING. * SAYS ALL OF SHARES IN OFFERING ARE TO BE SOLD BY AGIOS Source text for Eikon: Further company coverage:
Promising responses seen with Agios leukemia drug in study
Nearly a third of patients with an advanced form of a fast-progressing leukemia who carry a specific genetic mutation experienced a complete or near complete response to an experimental Agios Pharmaceuticals (AGIO) drug, according to data from an early stage trial released on Monday.
AgroFresh Solutions, Inc.AGFS
AgroFresh Solutions, Inc.AGFSW
Aimmune Therapeutics, Inc.AIMT
Air Methods CorporationAIRM
Air T, Inc.AIRT
Air Transport Services Group, IncATSG
AirMedia Group IncAMCN
Akamai Technologies, Inc.AKAM
Akebia Therapeutics, Inc.AKBA